[Blood plasma lipids and apolipoproteins as indicators of coronary atherosclerosis]. 1986

V A Polesskiĭ, and Kh A Kurdanov, and V A Metel'skaia, and G I Burlutskiĭ, and A D Deev

An assessment of one-feature and combined diagnostic value of plasma lipid and apolipoprotein parameters, using stepwise discriminant analysis, was designed to make possible correct differentiation between coronary heart disease (CHD) due to angiographically-verified coronary atherosclerosis and neurocirculatory dystonia (NCD) without signs of coronary arterial affection. The apolipoprotein B/apolipoprotein AI (apo B/apo AI) ratio was shown to be the best single apolipoprotein marker capable of correct differentiation between CHD and NCD in 74% of cases. It was similar to the best lipid diagnostic marker, the cholesterol atherogenic index, in terms of discriminating power. The combination of the apo B/apo AI ratio + age + systolic arterial blood pressure proved to be the best combined indicator, bringing the diagnostic error down to 18%.

UI MeSH Term Description Entries
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009449 Neurocirculatory Asthenia A clinical syndrome characterized by palpitation, SHORTNESS OF BREATH, labored breathing, subjective complaints of effort and discomfort, all following slight PHYSICAL EXERTION. Other symptoms may be DIZZINESS, tremulousness, SWEATING, and INSOMNIA. Neurocirculatory asthenia is most typically seen as a form of anxiety disorder. Cardiac Neurosis,Effort Syndrome,Hyperkinetic Heart Syndrome,Phobia, Cardiac,Asthenia, Neurocirculatory,Cardiac Neuroses,Cardiac Phobia,Heart Syndrome, Hyperkinetic,Neurocirculatory Asthenias,Neurosis, Cardiac,Syndrome, Effort,Syndrome, Hyperkinetic Heart
D003324 Coronary Artery Disease Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause. Arteriosclerosis, Coronary,Atherosclerosis, Coronary,Coronary Arteriosclerosis,Coronary Atherosclerosis,Left Main Coronary Artery Disease,Left Main Coronary Disease,Left Main Disease,Arterioscleroses, Coronary,Artery Disease, Coronary,Artery Diseases, Coronary,Atheroscleroses, Coronary,Coronary Arterioscleroses,Coronary Artery Diseases,Coronary Atheroscleroses,Left Main Diseases
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001053 Apolipoproteins Protein components on the surface of LIPOPROTEINS. They form a layer surrounding the hydrophobic lipid core. There are several classes of apolipoproteins with each playing a different role in lipid transport and LIPID METABOLISM. These proteins are synthesized mainly in the LIVER and the INTESTINES. Apolipoprotein
D017023 Coronary Angiography Radiography of the vascular system of the heart muscle after injection of a contrast medium. Angiography, Coronary,Angiographies, Coronary,Coronary Angiographies

Related Publications

V A Polesskiĭ, and Kh A Kurdanov, and V A Metel'skaia, and G I Burlutskiĭ, and A D Deev
January 1983, Annales de medecine interne,
V A Polesskiĭ, and Kh A Kurdanov, and V A Metel'skaia, and G I Burlutskiĭ, and A D Deev
November 1983, Annals of internal medicine,
V A Polesskiĭ, and Kh A Kurdanov, and V A Metel'skaia, and G I Burlutskiĭ, and A D Deev
October 1983, Atherosclerosis,
V A Polesskiĭ, and Kh A Kurdanov, and V A Metel'skaia, and G I Burlutskiĭ, and A D Deev
December 1993, The Tokushima journal of experimental medicine,
V A Polesskiĭ, and Kh A Kurdanov, and V A Metel'skaia, and G I Burlutskiĭ, and A D Deev
February 1992, La Tunisie medicale,
V A Polesskiĭ, and Kh A Kurdanov, and V A Metel'skaia, and G I Burlutskiĭ, and A D Deev
April 1983, Presse medicale (Paris, France : 1983),
V A Polesskiĭ, and Kh A Kurdanov, and V A Metel'skaia, and G I Burlutskiĭ, and A D Deev
March 1973, Chest,
V A Polesskiĭ, and Kh A Kurdanov, and V A Metel'skaia, and G I Burlutskiĭ, and A D Deev
November 1972, Sovetskaia meditsina,
V A Polesskiĭ, and Kh A Kurdanov, and V A Metel'skaia, and G I Burlutskiĭ, and A D Deev
April 1979, Lancet (London, England),
V A Polesskiĭ, and Kh A Kurdanov, and V A Metel'skaia, and G I Burlutskiĭ, and A D Deev
January 2019, Journal of Alzheimer's disease : JAD,
Copied contents to your clipboard!